中 / EN

BCIwiki — Brain-computer interface news, research and industry database

Latest

July 2026

Preprint: Triad Interviews With Stroke Survivors Expose Three XAI Elicitation Biases

Researchers report a preprint, posted to arXiv on July 28, 2026 and not yet peer reviewed, on the methodological problem of eliciting explainable AI (XAI) requirements from stroke survivors. Existing protocols run dyadic interviews and overlook facilitation dynamics; this formative study moved to a survivor-caregiver triad, with three stroke survivors (two with moderate-to-severe aphasia) and three caregivers, and facilitators used four scaffolding techniques: analogical bridging, projective personas, binary forcing and extended response time. A reflexive analysis identified three systematic facilitation biases — normative bias, hypothesis confirmation bias and the presence effect — which the authors present as protocol risk guidelines for practitioners.
Why it matters Explainability requirements gate the clinical uptake of AI-driven rehabilitation, and this preprint moves the failure point from the algorithm to the interview room — its dyad-to-triad redesign is a usable protocol risk guide, though with three survivors it is a hypothesis about elicitation, not evidence about stroke patients.

Neurotech Leaders Forum Returns to imec With Europe at an Inflection Point

The second annual Neurotech Leaders Forum drew executives, investors, researchers and regulators from Europe and the United States to imec's campus in Leuven, Belgium, on June 23-24, 2026, for sessions on clinical translation, capital formation, regulatory strategy and emerging frontiers. Thomas Stieglitz of the University of Freiburg gave the Day 1 keynote, arguing for perseverance and functionalist design, and later sessions covered women's health, European BCI ventures and the region's capital and regulatory challenges. Companies showing new work included WISE SpA, with its Heron spinal cord stimulation lead, and Melora Medical, with a transcutaneous auricular vagus nerve stimulation (taVNS) device for dermatology.
Why it matters The forum's second edition is a read on where Europe's neurotech sector actually stands, and the agenda's weight on capital formation and regulatory strategy rather than device science says more about the region's bottleneck than any single product on show.

EPFL launches clinical study of brain-controlled spinal cord stimulation for lower-limb recovery

Ecole Polytechnique Fédérale de Lausanne (EPFL) has launched a clinical study evaluating the preliminary safety and effectiveness of a cortical recording device (ECoG) combined with lumbar targeted epidural electrical stimulation (EES) to restore voluntary lower-limb motor function in participants with chronic spinal cord injury and mobility impairment. The study aims to establish a direct bridge between motor intention and the spinal cord below the lesion, potentially improving or restoring voluntary leg control and promoting neurological recovery when combined with neurorehabilitation.
Why it matters This study is among the first to combine cortical recording with spinal cord stimulation, forming a brain-spine interface to restore lower-limb movement in chronic spinal cord injury. It is an early-stage trial that will test the safety and preliminary effectiveness of this approach.

Hospices Civils de Lyon trial decodes motor imagery for stroke rehab

Hospices Civils de Lyon has registered a clinical study in France to decode motor imagery from non-invasive brain recordings as a prerequisite for innovative motor rehabilitation therapies. Combining MRI, MEG, and EEG, the study will design a subject-specific neurophysiological model, noting that standard BCI approaches neglect transient features such as beta bursts. The approach will first be validated in healthy subjects, then assessed for feasibility in stroke patients.
Why it matters This study is among the first to incorporate transient features like beta bursts into non-invasive BCI decoding of motor imagery, challenging the traditional ERD/ERS paradigm based on averaged power. If successful, it could offer more precise BCI training for post-stroke motor rehabilitation. Currently at an early feasibility stage with few patients, results remain to be validated.

Preprint: Simultaneous Decoding of Kinetic and Kinematic Movement Parameters by Noninvasive Brain Imaging

A preprint proposes three regression models — a partial least squares regressor, a multilayer perceptron and an attention-based regressor — to decode multiple kinematic and kinetic parameters of grasp-and-lift tasks simultaneously from EEG signals. Evaluated on the WAY EEG GAL dataset, the attention-based regressor performed best with an R² of 0.8 and 29.2 ms latency, markedly improving simultaneous multi-parameter decoding, though per-parameter decoding declined; the multilayer perceptron was more consistent across the two settings but less accurate (R² = 0.49). The study has not been peer reviewed.
Why it matters What makes the result worth tracking is the 29 ms latency on simultaneous multi-parameter decoding from non-invasive EEG — close to the real-time envelope needed for multi-command control — though as an unreviewed preprint the numbers are provisional.

Preprint: EEGForceFusion for Subject-Independent Grasp Force Decoding

A preprint proposes EEGForceFusion, a hybrid EEG decoding framework that jointly models continuous and tokenized representations for grasp-force decoding, where continuous decoding is limited by complex temporal dynamics, high inter-subject variability and poor generalization. The framework combines convolutional-recurrent representation learning, quantized tokenization and Transformer-based temporal modeling in a unified fusion regression architecture to capture both fine-grained neural structure and long-range temporal dependencies. Under strict leave-one-subject-out cross-validation on the WAY-EEG-GAL dataset, it reached an offline R² of 0.817 and a simulated real-time R² of 0.793, with latency suited to real-time deployment. The study has not been peer reviewed.
Why it matters The leave-one-subject-out R² of 0.817 offline and 0.793 in simulated real time is significant because it demonstrates cross-subject generalization — decoding grasp force without per-user calibration, the practical hurdle keeping force decoding out of real-time, subject-independent BCI deployments.

Preprint: UnSPC Cyclic Adaptation-Generalization Framework for Long-Term BMIs

A preprint proposes UnSPC (uncertainty-guided self-paced cyclic learning), a framework that integrates domain adaptation (DA) and domain generalization (DG) in an iterative cycle to address neural drift in long-term invasive brain-machine interfaces, where drift erodes decoding performance and forces frequent recalibration and where existing methods rely on DA or DG alone. Under an uncertainty-guided, self-paced pseudo-labeling scheme with a noise-robust ranking strategy, UnSPC iteratively mines reliable pseudo-labeled samples and, through cyclic adaptation and generalization, gradually mitigates both global and sub-domain drift. Experiments on multiple neural decoding datasets validated its effectiveness and robustness; the authors say it is the first method to integrate DA and DG through a pseudo-label loop. The study has not been peer reviewed.
Why it matters Neural drift is the quiet killer of long-term implants — performance decays and users must repeatedly recalibrate — so a framework that loops domain adaptation and generalization together, rather than picking one, targets the drift problem where invasive BCIs actually spend their lives: weeks and months after implantation.

VA optimizes implanted BCI to help paralyzed veterans use computers at home

The VA Office of Research and Development is advancing a high-performance implanted brain-computer interface (BCI) to improve independence for Veterans and others with tetraplegia or inability to speak due to ALS, spinal cord injury, or stroke. The project enhances deep learning decoders and multi-state gesture decoding, deployed on a battery-powered mobile BCI device for independent home use of computers and touch-enabled devices. Accuracy and usability will be evaluated in participants already enrolled in the BrainGate investigational clinical trial.
Why it matters VA Office of Research and Development is advancing a high-performance implanted BCI for Veterans with paralysis, enhancing deep learning decoders and multi-state gesture decoding deployed on a battery-powered mobile BCI device for independent computer and touch-device use at home; accuracy and usability will be evaluated in participants enrolled in the BrainGate investigational clinical trial.

Spatial Proteomic Analysis of Antimicrobial Therapeutic-Releasing Intracortical Probes

The study uses spatial proteomics to assess tissue around non-functional intracortical microelectrodes implanted for four weeks in mice, measuring neuronal integrity, immune-cell activation and local cytokine expression around probes coated with drug-loaded, controlled-release titanium dioxide nanotube array (TNA) coatings. The authors note that blood-brain barrier disruption can translocate gut-derived bacteria to the implant site and sustain chronic inflammation, and that the TNA coating's therapeutic loading and controlled release further damp residual neuroinflammation. They conclude that TNA offers a multifunctional, tunable interface for locally regulating the neuroimmune microenvironment, a step toward long-term reliable intracortical recordings.
Why it matters Spatial proteomics turns the neuroimmune response — the factor that has long capped intracortical recording stability — into a measurable, tunable coating variable, supplying platform data for future recording- and stimulation-probe design.

NeuroXess 'Sanquan' BCI Enters CMDE Innovative Medical Device Review Program

NeuroXess announced that its self-developed implantable brain-computer interface system for hand motor function compensation — the 'fully implanted, fully wireless, fully functional' ('Sanquan') system — has passed public notice and formally entered the innovative medical device special review program of the National Medical Products Administration's Center for Medical Device Evaluation (CMDE), commonly known as the green channel. The company describes it as the first subdural implantable flexible BCI product in China to enter the program. The system began a GCP registration clinical trial at Huashan Hospital, Fudan University on July 7, 2026, run as a multicentre study across 15 Class III hospitals nationwide, with trial data intended to support a Class III medical device registration application with the NMPA. The system remains in the review and clinical-trial stage and has not yet been approved for market; the registration timeline reflects company statements and remains subject to regulatory notice.
Why it matters This is the first subdural implantable flexible BCI product in China to enter the CMDE innovative medical device special review program, advancing in parallel with its GCP registration trial whose data will support NMPA Class III registration—a key node in the regulatory pathway for domestic invasive BCIs worth tracking.

© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About